Onesource Specialty Pharma is currently trading at Rs. 1816.70, up by 54.20 points or 3.08% from its previous closing of Rs. 1762.50 on the BSE.

The scrip opened at Rs. 1840.10 and has touched a high and low of Rs. 1840.15 and Rs. 1792.50 respectively. So far 8115 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2249.65 on 18-Jun-2025 and a 52 week low of Rs. 1075.00 on 30-Jan-2026.

Last one week high and low of the scrip stood at Rs. 1870.00 and Rs. 1323.15 respectively. The current market cap of the company is Rs. 20858.08 crore.

The promoters holding in the company stood at 30.48%, while Institutions and Non-Institutions held 38.11% and 31.41% respectively.

OneSource Specialty Pharma has received an EU GMP Certificate of Compliance of a Manufacturer for its Sterile Product Division (SPD) facility from the competent German authority, the State Office for Occupational Safety, Social Affairs and Health of Schleswig-Holstein, Germany. The certificate, dated April 27, 2026, was issued following the latest inspection conducted on October 14, 2025, and confirms compliance with EU GMP requirements for sterile products. The certificate covers sterile products, including aseptically prepared small volume liquids, secondary packing and quality control testing.

Separately, the Sterile Product Division has capabilities across liquid vials, lyophilised vials, pre-filled syringes and autoinjectors, and holds approvals from US-FDA, Health Canada, ANVISA and TGA.

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.